IOMX - Trademark Details
Status: 700 - Registered
Serial Number
87802718
Registration Number
6236118
Word Mark
IOMX
Status
700 - Registered
Status Date
2021-01-05
Filing Date
2018-02-19
Registration Number
6236118
Registration Date
2021-01-05
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-10-20
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
WATTS-FITZGERALD, CAIT
Statements
Goods and Services
Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions
Goods and Services
Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit
Goods and Services
Scientific services, namely, scientific research, analysis and testing in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Scientific services, namely, scientific research, analysis and testing in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, as well as for controlling and managing patient medical information, with any of the aforementioned services for use in the fields of biology, chemistry or medicine, as well as for use in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, as well as for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, with any of the aforementioned services for use in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-02-26
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-02-26
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-26
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Brewster Taylor
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2017-08-18 | 017115247 | EU | True |
False |
Trademark Events
Event Date | Event Description |
2018-02-22 | NEW APPLICATION ENTERED IN TRAM |
2018-02-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-03-16 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2018-03-30 | ASSIGNED TO LIE |
2018-04-03 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
2018-06-04 | ASSIGNED TO EXAMINER |
2018-06-04 | NON-FINAL ACTION WRITTEN |
2018-06-04 | NON-FINAL ACTION E-MAILED |
2018-06-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-12-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-12-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-12-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-12-12 | SUSPENSION LETTER WRITTEN |
2018-12-12 | LETTER OF SUSPENSION E-MAILED |
2018-12-12 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
2019-06-18 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2019-12-18 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2020-06-24 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
2020-07-09 | FINAL REFUSAL WRITTEN |
2020-07-09 | FINAL REFUSAL E-MAILED |
2020-07-09 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2020-08-24 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2020-08-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-08-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-09-10 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-09-11 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
2020-09-15 | ELECTRONIC RECORD REVIEW COMPLETE |
2020-09-30 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-10-20 | PUBLISHED FOR OPPOSITION |
2020-10-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-01-05 | REGISTERED-PRINCIPAL REGISTER |
2021-10-08 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-10-08 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-10-08 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
2021-10-08 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
2021-10-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |